CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 31 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,647,000 | -49.5% | 7,820,000 | -44.4% | 0.72% | -36.9% |
| Q3 2018 | $13,155,000 | -14.5% | 14,070,000 | -1.4% | 1.14% | -7.0% |
| Q2 2018 | $15,394,000 | -18.8% | 14,270,000 | -12.3% | 1.23% | +0.4% |
| Q1 2018 | $18,966,000 | +38.6% | 16,280,000 | +61.2% | 1.22% | +51.3% |
| Q4 2017 | $13,682,000 | +100.2% | 10,100,000 | +150.6% | 0.81% | +126.7% |
| Q2 2017 | $6,833,000 | +85.7% | 4,030,000 | +41.4% | 0.36% | +82.6% |
| Q1 2017 | $3,680,000 | – | 2,850,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |